Imai, K.; Takai, K.; Miwa, T.; Taguchi, D.; Hanai, T.; Suetsugu, A.; Shiraki, M.; Shimizu, M.
Rapid Depletion of Subcutaneous Adipose Tissue during Sorafenib Treatment Predicts Poor Survival in Patients with Hepatocellular Carcinoma. Cancers 2020, 12, 1795.
https://doi.org/10.3390/cancers12071795
AMA Style
Imai K, Takai K, Miwa T, Taguchi D, Hanai T, Suetsugu A, Shiraki M, Shimizu M.
Rapid Depletion of Subcutaneous Adipose Tissue during Sorafenib Treatment Predicts Poor Survival in Patients with Hepatocellular Carcinoma. Cancers. 2020; 12(7):1795.
https://doi.org/10.3390/cancers12071795
Chicago/Turabian Style
Imai, Kenji, Koji Takai, Takao Miwa, Daisuke Taguchi, Tatsunori Hanai, Atsushi Suetsugu, Makoto Shiraki, and Masahito Shimizu.
2020. "Rapid Depletion of Subcutaneous Adipose Tissue during Sorafenib Treatment Predicts Poor Survival in Patients with Hepatocellular Carcinoma" Cancers 12, no. 7: 1795.
https://doi.org/10.3390/cancers12071795
APA Style
Imai, K., Takai, K., Miwa, T., Taguchi, D., Hanai, T., Suetsugu, A., Shiraki, M., & Shimizu, M.
(2020). Rapid Depletion of Subcutaneous Adipose Tissue during Sorafenib Treatment Predicts Poor Survival in Patients with Hepatocellular Carcinoma. Cancers, 12(7), 1795.
https://doi.org/10.3390/cancers12071795
